SCHEMBL7651950

SCHEMBL7651950

O=C(O)Cn1c(=O)n(CCCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)c(=O)c2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 10/20 0.54
LMNA P02545 2/20 0.48
NPC1 O15118 1/20 0.48
MLNR O43193 1/20 0.48
NR1I2 O75469 1/20 0.48
EGFR P00533 1/20 0.48
ERBB2 P04626 1/20 0.48
FYN P06241 1/20 0.48
CHRM2 P08172 1/20 0.48
CHRM4 P08173 1/20 0.48
ABCB1 P08183 1/20 0.48
ADRB1 P08588 1/20 0.48
HTR1A P08908 1/20 0.48
CHRM5 P08912 1/20 0.48
ADRA2A P08913 1/20 0.48
ADORA3 P0DMS8 1/20 0.48
CHRM1 P11229 1/20 0.48
ADRB3 P13945 1/20 0.48
DRD2 P14416 1/20 0.48
ADRA2B P18089 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7651155 0.96 BCHE (0.54) BCHELMNANPC1MLNRNR1I2
SCHEMBL7651863 0.94 BCHE (0.52) BCHELMNANPC1MLNRNR1I2
SCHEMBL7650856 0.92 BCHE (0.53) BCHELMNANPC1MLNRNR1I2
SCHEMBL7655637 0.92 BCHE (0.53) BCHELMNANPC1MLNRNR1I2
SCHEMBL7650486 0.92 BCHE (0.53) BCHELMNANPC1MLNRNR1I2
SCHEMBL7649679 0.92 BCHE (0.53) BCHELMNANPC1MLNRNR1I2
SCHEMBL7655890 0.92 BCHE (0.53) BCHELMNANPC1MLNRNR1I2
SCHEMBL7649650 0.91 BCHE (0.51) BCHELMNANPC1MLNRNR1I2
SCHEMBL7655620 0.91 BCHE (0.52) BCHELMNANPC1MLNRNR1I2
SCHEMBL7658755 0.91 BCHE (0.52) BCHELMNANPC1MLNRNR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6407116-B1 2,4-DIOXO-1,2,3,4-TETRAHYDROQUINAZOLINE DERIVATIVES; ANTIALLERGENS, ANTIASTHMATICS, ANTIHISTAMINES, AND ANTIINFLAMMATORY AGENTS TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2002-06-18 US disclosed
EP-1026160-A1 NITROGENOUS FUSED-RING COMPOUNDS, PROCESS FOR THE PREPARATION OF THE SAME, AND DRUGS Takeda Chemical Industries, Ltd. (JP) 2000-08-09 EP disclosed